TUMOR-SPECIFIC IMMUNE RESPONSE AFTER PHOTODYNAMIC THERAPY

par Yu. N. Anokhin, E. V. Abakushina
Publié 2016

POTENTIAL USAGE OF NK CELLS AND NKG2D-POSITIVE LYMPHOCYTES AS TARGETS IN THERAPY OF CROHN’S DISEASE

par E. A. Shulenina, E. V. Abakushina, E. Yu. Lyssuk
Publié 2017

Development of approaches for cellular immunotherapy of cancer patients

par Yu. V. Gelm, E. V. Abakushina, I. A. Pasova, L. Yu. Grivtsova
Publié 2021

INHIBITION OF THE NKG2D ACTIVATING RECEPTOR EXPRESSION ON CYTOTOXIC LYMPHOCYTES BY RECOMBINANT MICA PROTEIN

par E. V. Abakushina, E. Yu. Lyssuk, A. V. Posvyatenko, A. V. Kibardin
Publié 2017

LYMPHOCYTE SUBPOPULATIONS IN GASTRIC AND COLORECTAL CANCER PATIENTS AFTER IMMUNOTHERAPY WITH ACTIVATED LYMPHOCYTES

par E. V. Abakushina, Yu. V. Marizina, G. S. Neprina, I. A. Pasova, B. A. Berdov
Publié 2014

LYMPHOCYTE PHENOTYPE IN PATIENTS WITH SKIN MELANOMA AFTER IMMUNOTHERAPY OF ACTIVATED LYMPHOCYTES

par E. V. Abakushina, Yu. V. Marizina, G. S. Neprina, D. V. Kudryavtsev, G. T. Kudryavtseva, N. V. Selivanova
Publié 2015

CIRCULATING MICA PROTEIN IN PATIENTS WITH MALIGNANT LYMPHOMAS

par A. V. Klinkova, E. G. Kuzmina, E. V. Abakushina, L. M. Kanevskiy, G. S. Neprina, V. V. Pavlov, E. I. Kovalenko
Publié 2016